The dynamics of Fe2+ and nitric oxide (NO) metabolites levels in exhaled breath condensate (EBC) in long-term smokers Source: Annual Congress 2009 - Tobacco, bronchial tubes and the lung Year: 2009
The changes of nitric oxide metabolism and soluble forms of differentiated antigens levels in exhaled breath condensate (EBC) in Chernobyl clean-up workers with COPD Source: Annual Congress 2009 - Occupational exposures and disease II Year: 2009
Longitudinal analysis between exhaled nitric oxide (FeNO), inflammatory markers (IM) in exhaled breath condensate (EBC), lung function, and control/severity of childhood asthma Source: Annual Congress 2007 - Assessing asthma severity and control in children Year: 2007
Total nitrate/nitrite level (TNN) in exhaled breath condensate (EBC) as a comprehensive marker of nitric oxide synthesis in respiratory tract Source: Annual Congress 2007 - Airway regulation, provocation and monitoring I Year: 2007
Future perspectives on exhaled biomarkers Source: Eur Respir Monogr 2010; 49: 237-246 Year: 2010
Assessing inflammation non invasively: induced sputum, fractional exhaled nitric oxide concentration (FeNO), exhaled breath condensate (EBC) Source: Annual Congress 2006 - "Inflammometry": an alternative strategy in the management of airways disease Year: 2006
Exhaled nitric oxide (eNO) and pH in the exhaled breath condensate in asthmatic children: biomarkers of different inflammatory pathways? Source: Eur Respir J 2006; 28: Suppl. 50, 671s Year: 2006
Exhaled nitric oxide (eNO) and acidity of exhaled breath condensate (EBC pH) of children with asthma, cystic fibrosis (CF) and healthy controls Source: Eur Respir J 2005; 26: Suppl. 49, 42s Year: 2005
Dynamics of the nitric oxide metabolites in the exhaled breath condensate (EBC) in atopic asthma (BA) children receiving various treatment options Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013
Changes in the ratios of stable nitric oxide metabolites in the exhaled breath condensate in patients with COPD during antioxidant therapy. Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease Year: 2019
Concentrations of nitric oxide metabolites in the exhaled breath condensate in children with different bronchial asthma control Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012
Elevated exhaled nitric oxide without acidification of exhaled breath condensate in patients with mild asthma Source: Eur Respir J 2002; 20: Suppl. 38, 506s Year: 2002
Natural allergen exposure and nitric oxide (NO) metabolites in exhaled air condensate (EAC) of children with mite bronchial asthma (BA) Source: Eur Respir J 2003; 22: Suppl. 45, 131s Year: 2003
Nitrite/nitrate levels in exhaled breath condensate are increased but exhaled nitric oxide levels were not in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 788s Year: 2006
Investigation of nitric oxide level in the exhaled breath condensate in asthma and COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 281s Year: 2005
Nitric oxide metabolites and total IgE in exhaled air condensate (EAC) of the patients with bronchial asthma (BA) and allergen exposure Source: Eur Respir J 2002; 20: Suppl. 38, 604s Year: 2002
Concentration of nitric oxide in exhaled air (eNO) in patients with sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 434s Year: 2002
Prospective nitrite, nitrate and cys-leukotriene (cys-LTs ) measurements in EBC (exhaled breath condensate) in asthmatic children and relation to outcome during inhaled steroid (IS) reduction Source: Eur Respir J 2003; 22: Suppl. 45, 534s Year: 2003
Hydrogen peroxide in exhaled breath condensate and exhaled nitric oxide as non-invasive markers for childhood asthma Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009